52.52

1.02% -0.54

Scholar Rock Holding Corp (SRRK)

Overview News Price History Option Chain Financials Discussions Forecast

Scholar Rock Holding Corp stock is traded at $52.52, with a volume of 496.60K. It is down -1.02% in the last 24 hours and down -2.34% over the past month. Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

Previous Close:

$53.06

Open:

$52.94

24h Volume:

496.60K

Relative Volume:

0.37

Market Cap:

$6.40B

Revenue:

$47.30M

Net Income/Loss:

$-408.73M

P/E Ratio:

-14.64

EPS:

-3.5865

Net Cash Flow:

$-303.86M

1W Performance:

-0.76%

1M Performance:

-2.34%

6M Performance:

+14.22%

1Y Performance:

+62.65%

1-Day Range:

$51.50

$52.97

1-Week Range:

$50.69

$55.00

52-Week Range:

$27.07

$58.49

Scholar Rock Holding Corp Stock (SRRK) Company Profile

Name

Scholar Rock Holding Corp

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

857-259-3860

Address

301 BINNEY STREET, CAMBRIDGE, MA

Employee

289

Twitter

@ScholarRock

Next Earnings Date

2026-08-06

Latest SEC Filings

SRRK's Discussions on Twitter

Compare SRRK vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SRRK Scholar Rock Holding Corp	52.52	6.55B	47.30M	-408.73M	-303.86M	-3.5865
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-21-26	Initiated	Canaccord Genuity	Buy
Jan-09-26	Initiated	Citigroup	Buy
Nov-18-25	Initiated	Wolfe Research	Outperform
Oct-09-25	Initiated	BofA Securities	Buy
Sep-17-25	Initiated	Barclays	Overweight
Sep-15-25	Initiated	Leerink Partners	Outperform
Aug-21-25	Resumed	Jefferies	Buy
Jul-30-25	Resumed	Raymond James	Strong Buy
Jul-17-25	Initiated	Cantor Fitzgerald	Overweight
Nov-26-24	Reiterated	H.C. Wainwright	Buy
Oct-07-24	Reiterated	H.C. Wainwright	Buy
Mar-28-24	Initiated	Raymond James	Strong Buy
Oct-25-23	Upgrade	Jefferies	Hold → Buy
Apr-03-23	Resumed	Piper Sandler	Overweight
Sep-19-22	Resumed	H.C. Wainwright	Buy
Jul-12-22	Initiated	Truist	Buy
Mar-23-22	Initiated	H.C. Wainwright	Buy
Dec-22-21	Downgrade	Jefferies	Buy → Hold
Nov-19-21	Initiated	Piper Sandler	Overweight
Apr-26-21	Resumed	Credit Suisse	Outperform
Jan-11-21	Initiated	Credit Suisse	Outperform
Jan-06-21	Initiated	JP Morgan	Overweight
Mar-12-20	Initiated	Robert W. Baird	Outperform

View All

Scholar Rock Holding Corp Stock (SRRK) Latest News

Aug 14, 2026

Is Scholar Rock Holding Corporation (SRRK) Better Positioned than Novo Nordisk A/S (NVO) After Recent Setbacks? - Yahoo Finance

Aug 14, 2026

Redmile Group (SRRK) updates Scholar Rock stake to 3.6% of common stock - Stock Titan

Aug 14, 2026

12 New Hires Receive 51,947 Scholar Rock Equity Awards - Stock Titan

Aug 14, 2026

SRRK Stock Surges To Near Five-Year Highs – Here’s Why Analysts Are Bullish About Its Latest FDA Filing - Stocktwits

Aug 14, 2026

Aug 13, 2026

Scholar Rock (SRRK) Stock Looks Priced At A Premium Today - simplywall.st

Aug 13, 2026

SRRK Maintains by JP Morgan -- Price Target Raised to $63.00 - GuruFocus

Aug 13, 2026

Scholar Rock (NASDAQ:SRRK) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat

Aug 13, 2026

Invus reports 8.0% stake in Scholar Rock (SRRK) through 9.6M shares - Stock Titan

Aug 13, 2026

Aug 12, 2026

SRRK Stock Prediction: Huge SMA Drug Launch Breakthrough? (2026 Alert) The Rock (yAPbDwyblt) - Mshale

Aug 12, 2026

Scholar Rock at canaccord growth conference: approval path narrows By Investing.com - Investing.com Nigeria

Aug 12, 2026

Scholar Rock at canaccord growth conference: approval path narrows - Investing.com India

Aug 12, 2026

Aug 11, 2026

Scholar Rock Overcomes Manufacturing Hurdle to Keep Lead Drug FDA Review on Schedule - Sahm

Aug 11, 2026

Q3 EPS Estimates for Scholar Rock Cut by HC Wainwright - MarketBeat

Aug 11, 2026

Scholar Rock: Apitegromab's Approval Is Key, Here's My Take Moscow Victory Day Parade (Ok0Q1xN954) - Mshale

Aug 11, 2026

Bank of America Corp DE Buys 286,126 Shares of Scholar Rock Holding Corporation $SRRK - MarketBeat

Aug 11, 2026

Aug 10, 2026

SRRK Reiterated by Wedbush -- Maintains Price Target at $58.00 - GuruFocus

Aug 10, 2026

Scholar Rock's (SRRK) Outperform Rating Reiterated at Wedbush - MarketBeat

Aug 10, 2026

H.C. Wainwright reiterates Scholar Rock stock rating at buy By Investing.com - Investing.com South Africa

Aug 10, 2026

H.C. Wainwright reiterates Scholar Rock stock rating at buy - Investing.com

Aug 10, 2026

SRRK Reiterated by HC Wainwright & Co. -- Price Target Maintained at $65 - GuruFocus

Aug 10, 2026